Phosphodiesterase inhibitors. Part 6: Design, synthesis, and structure–activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity

Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

Milton Packer, Joseph R. Carver, Richard J. Rodeheffer et al. · New England Journal of Medicine · 1991 · 2.2K citations · Full text

Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

Klaus F. Rabe, Eric Bateman, Denis O’Donnell et al. · The Lancet · 2005 · 466 citations

Asthma, Inflammation, Antifibrotic Therapy +6

Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

G.L. Card, B.P. England, Yoshihisa Suzuki et al. · Structure · 2004 · 425 citations · Full text

Drug Target, Biochemistry, Medicine +6

Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.

Theodore J. Torphy, Bradley J. Undem, L B Cieslinski et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 165 citations

The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family

Lucien C.D. Gibson, Stuart F. Hastings, Ian McPhee et al. · European Journal of Pharmacology · 2006 · 146 citations

Human Phosphodiesterase, Inhibitory Profile, Biochemistry +7